CLARIS Avocats advises the managing shareholders of the INVOKE group
publisher of financial reporting software, in connection with its sale by the ISAI and SAGARD funds to the German group REGNOLOGY, a major software publisher specializing in regulatory reporting solutions.
CLARIS Avocats advises the founding shareholders of DAUPHINE AM
a management company dedicated to top executives and their families, in connection with its sale to the RHETORES FINANCE group and the reinvestment of the founders in the purchaser.
CLARIS Avocats advises the shareholders and managers of the real estate development group PERSPECTIVE HABITAT
in the context of its sale to the ALSEI Group
CLARIS Avocats advises the selling and reinvesting shareholders
in an OBO relating to the MALHERBE freight transport group
CLARIS Avocats advises ARKEA CAPITAL
as part of its acquisition of a minority stake in COHERENCE, an agency specializing in digital communication that assists small and medium-sized businesses in their web visibility strategy
CLARIS Avocats advises the management of the SEAT VENTILATION group
French equipment manufacturer and leader in toxic gas and vapour extraction systems, in a secondary LBO transaction with the support of the Capital Export fund, alongside the management, which retains a minority stake
CLARIS Avocats advises the management of the Digital Testing activity of EUROFINS
in connection with its sale to the British private equity fund Stirling Square Capital Partners
CLARIS Avocats advises ALIAD, the Air Liquide venture capital fund
Ekoscan Integrity, a European provider of integrated technological solutions for ultrasonic non-destructive testing (NDT), raised €23 million from the investment fund Abénex, the venture capital company EDF Pulse Ventures and ALIAD, its historical strategic investor
CLARIS Avocats advises ABENEX CROISSANCE
in the acquisition of a minority stake in the IPSSI Group, a school of higher education in the IT sector, as part of a primary OBO
CLARIS Avocats advises the shareholder-managers of the TRACTEL group
in the context of its sale by the CINVEN fund to the Swedish group ALIMAK
